|
TMEM14C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.644900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.643800E-03 |
| Normal-vs-Stage2 |
3.536100E-02 |
| Normal-vs-Stage3 |
1.759310E-03 |
| Normal-vs-Stage4 |
1.09349999999342E-06 |
| Stage1-vs-Stage2 |
9.689200E-01 |
| Stage1-vs-Stage3 |
3.218400E-01 |
| Stage1-vs-Stage4 |
3.397700E-03 |
| Stage2-vs-Stage3 |
5.652400E-01 |
| Stage2-vs-Stage4 |
6.640500E-02 |
| Stage3-vs-Stage4 |
9.501600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.023100E-04 |
| Normal-vs-AfricanAmerican |
1.158600E-01 |
| Normal-vs-Asian |
1.040540E-03 |
| Caucasian-vs-AfricanAmerican |
4.188400E-01 |
| Caucasian-vs-Asian |
9.759200E-01 |
| AfricanAmerican-vs-Asian |
4.203600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.876400E-03 |
| Normal-vs-Female |
9.034100E-04 |
| Male-vs-Female |
6.339600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.781320E-03 |
| Normal-vs-Age(41-60Yrs) |
2.501900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.362100E-04 |
| Normal-vs-Age(81-100Yrs) |
9.722400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.297600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.350800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.665400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.600200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.462800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.696200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.570400E-01 |
| Classical-VS-Follicular |
8.379900E-02 |
| Classical-VS-Other |
4.591800E-01 |
| Classical-VS-Normal |
1.223220E-04 |
| Tall-VS-Follicular |
2.519600E-01 |
| Tall-VS-Other |
6.696400E-01 |
| Tall-VS-Normal |
1.008240E-02 |
| Follicular-VS-Other |
9.800800E-01 |
| Follicular-VS-Normal |
1.474210E-01 |
| Other-VS-Normal |
4.334400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.122300E-03 |
| Normal-vs-N1 |
8.28330000000044E-05 |
| N0-vs-N1 |
6.609600E-02 |
|
|
